triclosan has been researched along with Cancer of the Retina in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, three inhibitors targeting different domains of FASN--cerulenin, triclosan and orlistat--were evaluated for their anti-proliferative efficacy in ocular cancer, retinoblastoma (RB) cells and their toxicity (if any) in normal cells." | 3.78 | Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells. ( Deepa, PR; Jayanthi, U; Krishnakumar, S; Vandhana, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deepa, PR | 1 |
| Vandhana, S | 1 |
| Jayanthi, U | 1 |
| Krishnakumar, S | 1 |
1 other study available for triclosan and Cancer of the Retina
| Article | Year |
|---|---|
Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells.
Topics: 3T3 Cells; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Ceru | 2012 |